Clinicopathologic characteristics and prognosis of ERBB2-low breast cancer among patients in the National Cancer Database DS Peiffer, F Zhao, N Chen, OM Hahn, R Nanda, OI Olopade, D Huo, ... JAMA oncology 9 (4), 500-510, 2023 | 52 | 2023 |
The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort F Zhao, TO Henderson, TM Cipriano, BL Copley, M Liu, R Burra, SH Birch, ... Cancer 127 (21), 4072-4080, 2021 | 30 | 2021 |
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes F Zhao, B Copley, Q Niu, F Liu, JA Johnson, T Sutton, G Khramtsova, ... Breast cancer research and treatment 185, 841-849, 2021 | 29 | 2021 |
Racial disparities in pathological complete response among patients receiving neoadjuvant chemotherapy for early-stage breast cancer F Zhao, M Miyashita, M Hattori, T Yoshimatsu, F Howard, K Kaneva, ... JAMA Network Open 6 (3), e233329-e233329, 2023 | 13 | 2023 |
Response to treatment, racial and ethnic disparity, and survival in patients with breast cancer undergoing neoadjuvant chemotherapy in the US S Shubeck, F Zhao, FM Howard, OI Olopade, D Huo JAMA Network Open 6 (3), e235834-e235834, 2023 | 13 | 2023 |
Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach G Gao, F Zhao, TU Ahearn, KL Lunetta, MA Troester, Z Du, TO Ogundiran, ... Human molecular genetics 31 (18), 3133-3143, 2022 | 13 | 2022 |
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African … M Miyashita, JSK Bell, S Wenric, E Karaesmen, B Rhead, M Kase, ... Breast Cancer Research 25 (1), 1-13, 2023 | 12 | 2023 |
Development and external validation of a breast cancer absolute risk prediction model in Chinese population Y Han, J Lv, C Yu, Y Guo, Z Bian, Y Hu, L Yang, Y Chen, H Du, F Zhao, ... Breast Cancer Research 23 (1), 1-13, 2021 | 10 | 2021 |
Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis H Li, C Geng, H Zhao, H Jiang, G Song, J Zhang, Y Liu, X Gui, J Wang, ... Chinese Journal of Cancer Research 33 (2), 243, 2021 | 9 | 2021 |
Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancer H Li, Y Xu, F Zhao, G Song, HS Rugo, Y Zhang, L Yang, X Liu, B Shao, ... American Journal of Cancer Research 8 (9), 1873, 2018 | 8 | 2018 |
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer E Terman, J Sheade, F Zhao, FM Howard, N Jaskowiak, J Tseng, N Chen, ... Breast Cancer Research and Treatment 200 (1), 75-83, 2023 | 6 | 2023 |
External Evaluation of a Mammography-based Deep Learning Model for Predicting Breast Cancer in an Ethnically Diverse Population OJ Omoleye, AE Woodard, FM Howard, F Zhao, TF Yoshimatsu, Y Zheng, ... Radiology: Artificial Intelligence, e220299, 2023 | 2 | 2023 |
Stress, Isolation, and Sleep Quality among Breast Cancer Survivors throughout the COVID-19 Pandemic: A Longitudinal Study in a Multi-Ethnic Cohort F Zhao, JQ Freeman, N Jaskowiak, GF Fleming, R Nanda, DS Lauderdale, ... | 1 | 2023 |
Abstract SS1-06: Racial disparities in pathological complete response among breast cancer patients receiving neoadjuvant chemotherapy F Zhao, M Steiner, A Ibraheem, G Fleming, N Jaskowiak, R Nanda, ... Cancer Research 81 (4_Supplement), SS1-06-SS1-06, 2021 | 1 | 2021 |
Demographic and Clinical Characteristics Associated With Familiarity, Interest, and Use of Integrative Therapies Among Patients With Breast Cancer JQ Freeman, J Sheade, F Zhao, OI Olopade, R Nanda, D Huo Integrative Cancer Therapies 22, 15347354231185122, 2023 | | 2023 |
Abstract P6-05-19: Racial Disparities in the Quality of Life and Vaccination of Breast Cancer Survivors during COVID-19: A Longitudinal Study F Zhao, BL Copley, SH Birch, R Nanda, OI Olopade, D Huo Cancer Research 83 (5_Supplement), P6-05-19-P6-05-19, 2023 | | 2023 |